These are fair questions, and the answers are mostly reassuring. Understanding what a biosimilar is, and what does and does not change, puts you back in control of the switch.

Key points

• • A biosimilar is a highly similar version of a biologic medicine, assessed in Australia as working the same way with no clinically meaningful differences.
  • Published international research has found no difference in safety or results for people who switch.
  • Your specialist can ask for your brand to stay the same by ticking "brand substitution not permitted" on your script.
  • A new brand may come with a different pen, so ask for a demonstration before your first dose.

What is a biosimilar?

Biologics are medicines made from living cells rather than simple chemicals. They are large, complex molecules, which is why they cannot be copied exactly the way ordinary tablets can. Even the original brand varies very slightly from batch to batch.

Once the patent on an original biologic, called the reference medicine, runs out, other companies can make their own version. That version is a biosimilar. Before it can be sold in Australia, the Therapeutic Goods Administration assesses it in detail. It is only approved if it shows no clinically meaningful differences from the reference medicine, which means it works the same way, at the same dose, with the same expected benefits and side effects.

Why are biosimilars being used?

Biologics are some of the most expensive medicines on the PBS. When biosimilars become available, competition between brands brings the cost down. That helps keep these treatments affordable and available for everyone who needs them, now and in the future.

For you, the price at the pharmacy counter is generally the standard PBS copayment either way. The switch is about keeping the system sustainable, not about giving you a lesser treatment.

Is it safe to switch?

The evidence says yes. Published international studies have found no difference in safety or health outcomes for people who switched from a reference biologic to a biosimilar. Biosimilars also continue to be monitored for safety after they reach the market, just like the original brands.

It is still normal to feel wary. Researchers have noticed that when people expect a change to go badly, they can notice more symptoms, even when the medicine itself is working the same way. Those symptoms are real and worth reporting. Knowing this can simply help you give a new brand a fair chance, while keeping your specialist informed of any genuine change.

Who decides what brand I should get?

Your specialist makes the prescribing decision. For some biologics, your pharmacist is allowed to substitute one brand for another, in the same way generics are swapped for everyday medicines, and they should discuss this with you. If there is a reason to stay on one brand, your specialist can tick "brand substitution not permitted" on the script, and the pharmacy must dispense exactly that brand.

If you have concerns about switching, raise them at your next appointment. It is a reasonable conversation to have, and your specialist can explain what makes sense for you.

What actually changes when I switch?

The medicine itself works the same way, and your dose and schedule usually stay the same. What can change is everything around it:

• • the brand name and packaging
  • the pen or syringe, including how it clicks, where the button is and how long to hold it
  • storage details, such as how long it can stay out of the fridge
  • the leaflet and injection steps.

Ask for a device demonstration before your first dose, and keep any old and new stock clearly separated. It also helps to note the brand name and batch number of each supply, which makes it easier to report any side effects accurately.

How Ace can help

A switch goes smoothly when nothing about it is a surprise. Ace pharmacists will let you know when a brand is changing, walk you through a new device before your first dose, and record the brand and batch you receive. Where your specialist has asked for a particular brand, we dispense exactly what is written. Get started with Ace.

References

Australian Government Department of Health. Biosimilar medicines, the basics for consumers and carers.

Australian Government Department of Health. Biosimilar medicines: the basics for health care professionals.

Pharmaceutical Benefits Scheme. Biosimilars on the PBS.

Arthritis Australia and Australian Rheumatology Association. Biosimilars information sheet.

This article is for general information only and does not constitute medical advice. Talk to your rheumatologist before making any change to your biologic treatment.